Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms Read More > July 21, 2020
In vitro structure-activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor Read More > July 5, 2020
The pharmacological interaction of compounds in ayahuasca: a systematic review Read More > July 3, 2020
Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials Read More > July 1, 2020
Stability Evaluation of DMT and Harmala Alkaloids in Ayahuasca Tea Samples Read More > April 29, 2020
In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation. Read More > January 13, 2020
4-MeO-PCP and 3-MeO-PCMo, new dissociative drugs, produce rewarding and reinforcing effects through activation of mesolimbic dopamine pathway and alteration of accumbal CREB, deltaFosB, and BDNF levels Read More > December 11, 2019
Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment Read More > December 10, 2019
Locomotor effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in mice: psychostimulant effects, stereotypy, and sensitization Read More > November 15, 2019
